Navigation Links
Ethicon Endo-Surgery Launches New Echelon Flex(TM) Endopath(R) Stapler That Delivers Echelon(TM) Compression, Now With Natural Articulation
Date:10/12/2009

CHICAGO, Oct. 12 /PRNewswire/ -- Ethicon Endo-Surgery today announced the launch of the Echelon Flex(TM) Endopath® Stapler, which delivers system wide compression in a novel way through the first and only articulating mechanical endocutter designed to be fully operated with one hand. The one-handed design of the device, which builds upon other proven Echelon(TM) Endopath® products with the addition of a wider jaw and natural articulation, is intended to provide surgeons with improved access and precision in placing the device during surgery to help reduce tissue damage and surgical instrument exchanges. The endocutter is used to cut and staple tissue in a variety of surgical procedures, including bariatric, thoracic, colorectal, gynecologic, urologic and general surgery. The company unveiled the new product at the 95th Annual Clinical Congress of the American College of Surgeons (ACS).

"There has been a strong desire among surgeons for a one-handed, articulating mechanical stapler, so the Echelon Flex(TM) Endopath® has the potential to fill that demand," said Alan Wittgrove, M.D., laparoscopic gastric bypass surgeon of the Wittgrove Bariatric Surgery Center and former president of the American Society for Metabolic and Bariatric Surgery*. "For me, this latest device from the Echelon product line is the most intuitive stapler I've used. A surgeon's ability to gently and precisely manipulate tissue is a critical component when evaluating the overall success of a surgery. Improved access through articulation in an endocutter can help improve the surgical experience for the surgeon."

As surgical devices have evolved to enable minimally invasive surgery, a surgeon's physical interaction with tissue has increasingly become more complex and to some degree, indirect. To help surgeons reduce tissue damage associated with the use of an endocutter, tissue dynamics, and the way in which devices interact with tissue, were at the forefront in the design and development of the Echelon Flex(TM) Endopath® Stapler.

The Echelon Flex(TM) Endopath® Stapler is equipped with a wide proximal-to-distal jaw to provide easy tissue positioning and facilitate gentle manipulation. The natural articulation capabilities of the endocutter, combined with the one-handed operation of the device, represent a significant advancement when compared to traditional lever-based, two-handed endocutters. Surgeons will gain greater access to transection sites that are difficult to reach and increase their precision in placing the device. As with the entire Echelon(TM) line, system wide compression may provide more consistent staple formation for hemostasis in a wide variety of tissue thickness. Proper staple formation is critical to providing hemostasis and avoiding leaks.

The ability to operate the Echelon Flex(TM) Endopath® Stapler with one hand may also reduce instrument exchange between surgeon and surgical team, decreasing interruptions and enhancing focus on the surgical field. The one-handed operation capabilities are complemented by a shorter grip span intended to improve comfort and ease of use for surgeons.

The Echelon Flex(TM) Endopath® Stapler, designed in collaboration with surgeons, is the latest offering from the company's Echelon(TM) Endopath® line of surgical stapling products, which have been uniquely developed to grasp, hold and manipulate tissue without the use of a second device. As with all Ethicon Endo-Surgery products, the Echelon(TM) Endopath® line is designed to enable the surgeon to attain the desired patient outcome. Understanding tissue dynamics and the effects of surgery upon the tissue is at the foundation of product development at Ethicon Endo-Surgery.

About Ethicon Endo-Surgery

Ethicon Endo-Surgery develops and markets advanced medical devices for minimally invasive and open surgical procedures, focusing on procedure-enabling devices for the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, gynecology and surgical oncology. More information can be found at www.ethiconendo.com.

*paid consultant for Ethicon Endo-Surgery

SOURCE Ethicon Endo-Surgery


'/>"/>
SOURCE Ethicon Endo-Surgery
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Ethicon Endo-Surgery Studies Presented at DDW Demonstrate Potential of Pure NOTES Surgery With Companys Toolbox
2. First Patient of NOTES Investigational Device Exemption (IDE) Study Successfully Treated With Ethicon Endo-Surgery Devices
3. Ethicon Endo-Surgery Wins Prestigious International Design Award for Innovative Development of HARMONIC FOCUS(TM)
4. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
5. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
6. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
7. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
8. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
9. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
10. Premier Micronutrient Launches Supplement for Hearing Health
11. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... SYDNEY , June 26, 2016 One of ... , has announced the formation of a new biotechnology company, Noxopharm ... raise $6m in an IPO and to list on the ASX. ... drug candidate, NOX66, ready to enter a Phase 1 clinical study ... been designed to address one of the biggest problems facing cancer ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Comfort ... the American Cancer Society and the Road To Recovery® program to drive cancer patients ... seniors and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
Breaking Medicine News(10 mins):